Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-647-7 | CAS number: 1474044-68-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted similarly to OECD test guideline 414 with acceptable restrictions. The study was performed on a formulation containing an analogue substance (for justification of read-across, please refer to the corresponding assessment report in Section 13).
Data source
Reference
- Reference Type:
- publication
- Title:
- Teratology and percutaneous toxicity studies on hair dyes.
- Author:
- C. Burnett. E. I. Goldenthal, S. B. Harris, F. X. Wazeter. J . Strausburg, R. Kapp, R. Voelker.
- Year:
- 1 976
- Bibliographic source:
- Journal of Toxicology and Environmental Health, 1: 1027-1040, 1976.
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- yes
- Remarks:
- Only one dose was tested. The animals were treated once every three days during the gestation period instead of daily.
- GLP compliance:
- no
- Remarks:
- study conducted before GLP implementation
- Limit test:
- yes
Test material
- Reference substance name:
- Sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate
- EC Number:
- 239-032-7
- EC Name:
- Sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate
- Cas Number:
- 14960-06-6
- IUPAC Name:
- Sodium Lauriminodipropionate
- Test material form:
- other: liquid
- Details on test material:
- - Common name : Sodium lauriminodipropionate
- For more details, see below the Confidential details for test material
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CD
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River
- Age at study initiation: no data
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: individually (the mated females)
- Diet (e.g. ad libitum): ad libitum (Ralston Purina Laboratory)
- Water (e.g. ad libitum): ad libitum (Ralston Purina Laboratory)
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): controlled during the study.
- Humidity (%): controlled during the study.
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
Administration / exposure
- Route of administration:
- dermal
- Type of inhalation exposure (if applicable):
- other: not applicable
- Vehicle:
- water
- Details on exposure:
- TEST SITE
- Area of exposure: the dorso-scapular area.
- % coverage: no data
- Type of wrap if used: no data
- Time intervals for shavings or clipplings: 1 day
REMOVAL OF TEST SUBSTANCE
- Washing (if done): no data
- Time after start of exposure: no data
TEST MATERIAL
- Concentration (if solution): 20 mL/Kg
USE OF RESTRAINERS FOR PREVENTING INGESTION: no data - Analytical verification of doses or concentrations:
- not specified
- Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: no data
- Length of cohabitation: no data
- Further matings after two unsuccessful attempts: no data
- Verification of same strain and source of both sexes: no data
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy
- Any other deviations from standard protocol: no data - Duration of treatment / exposure:
- Days 1, 4, 7, 10, 13, 16 and 19 of gestation
- Frequency of treatment:
- Once every three days during the gestation period
- Duration of test:
- From gestation day 1 to 20 (sacrifice)
- No. of animals per sex per dose:
- 20 pregnant rats/dose
- Control animals:
- yes, concurrent no treatment
- other: A positive control group received acetylsalicylic acid by gavage at a dose of 250 mg/kg on days 6 through 16 of gestation.
- Details on study design:
- No data
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: no data
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: no data
BODY WEIGHT: Yes
- Time schedule for examinations: determined on days 1, 4, 7, 10, 13, 16 and 19 of gestation.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 20
- Organs examined: no data - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Number if live and dead fetus: Yes - Fetal examinations:
- - External examinations: Yes: all per litter
- Soft tissue examinations: Yes: one-third per litter
- Skeletal examinations: Yes: two-third per litter
- Head examinations: No data - Statistics:
- The number of females exhibiting resorption sites, number of females exhibiting two or more resorptions, number of dead or resorbed fetuses, and the number of fetuses with soft-tissue or skeletal anomalies and accessory ribs was compared using chi-square test criterion or Fisher's exact probability test.
The mean number of corpora lutea, implantation sites, live fetuses, and resorption sites was compared by analysis of variance using Dunnett's multiple comparison tables to judge the significance of differences.
Statistically significant differences between groups were judged valid only when there were significant diffences between the dye treated group and each of the three untreated controls groups. - Indices:
- No data
- Historical control data:
- Not reported
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
- No signs of toxicity were seen throughout the study, except for the changes in the color of the skin and hair at the site of dye application. No irritation or other changes in appearance were seen.
- Changes in female body weights were similar for rats in the untreated controls and the treated group. A marked reduction in maternal weight gain through gestation was observed in the rats receiving acetyl-salicylic acid (positive control) as compared with either the untreated control rats or dye-treated rats.
- Mean food consumption for all groups (treated + untreated) throughout gestation was similar except for rats in the acetylsalicylic acid group; these rats showed a moderates decrease in food consumption from days 7 to 13 of gestation. This decrease was not seen from days 13 to 20 of gestation.
Effect levels (maternal animals)
- Dose descriptor:
- NOEL
- Effect level:
- 2 other: mL/Kg
- Based on:
- other: test formulation containing 1.5% of Sodium lauriminodipropionate
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
- No significant differences were observed between the treated and untreated groups in the mean number of corpora lutea, implantation sites and live fetuses and the sex ratio.
- No differences between groups were seen regarding the number of females exhibiting resorption sites or mean resorptions per pregnancy. No significant changes were observed regarding soft-tissue anomalies between the dye-treated group and the untreated control groups.
- The skeletal variations observed in this study was accessory ribs. However, this variation was more frequent in the untreated animals than the treated group.
- Increase in teratogenicity, increase in embryo-death and decrease in fetal weight were observed in the positive control group.
Effect levels (fetuses)
- Dose descriptor:
- NOEL
- Effect level:
- 2 other: mL/Kg
- Based on:
- other: test formulation containing 1.5% of Sodium lauriminodipropionate
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Table 7.8.2/2. Summary of Teratology Study in Rats receiving p-23 (test formulation containing 1.5% of Sodium lauriminodipropionate)
Observations |
Control I untreated |
Control II untreated |
Control III Iuntreated |
Acetylsalicylic acid (250 mg/kg-day) |
P-23 (2mL/Kg) (test formulation containing 1.5% of Sodium lauriminodipropionate) |
Maternal parameters |
|||||
Total no. females gravid |
20 |
20 |
20 |
20 |
20 |
Mean no. corpora lutea |
15.35 |
13.55 |
15.25 |
16.15 |
14.80 |
Mean no. implantation sites |
12.4 |
12.10 |
13.90 |
13.25 |
13.50 |
No. females exhibiting resorption sites |
13 |
14 |
12 |
15 |
12 |
No. females exhibiting 2 or more resorption sites |
9 |
7 |
6 |
15 |
6 |
No. females aborting |
0 |
0 |
0 |
0 |
0 |
Fetal parameters |
|||||
Mean no.live fetuses/group |
10.65 |
10.85 |
12.5 |
8.70 |
12.15 |
Mean live fetal weight (g) |
3.38 |
3.58 |
3.62 |
2.89 |
3.96 |
No. dead or resorbed fetuses (%) |
35 (14.11) |
25 (10.33) |
28 (10.07) |
91 (34.34) |
27 (10.00) |
Mean no. resorptions/pregnancy |
1.75 |
1.25 |
1.4 |
4.55 |
1.35 |
Sex ratio, M: F |
106:107 |
102:115 |
119:131 |
100:75 |
123:120 |
No. fetuses with soft-tissue anomalies (%) |
4 (6.35) |
4 (6.06) |
6 (7.79) |
21 (36.84) |
9 (12.16) |
No. fetuses with skeletal anomalies (%) |
0 (0.00) |
1 (0.67) |
2 (1.16) |
40 (34.19) |
3 (1.78) |
No. fetuses with accessory ribs only (%) |
75 (50.00) |
56 (37.09) |
72 (41.62) |
32 (27.35) |
66 (39.05) |
Applicant's summary and conclusion
- Conclusions:
- Under the test conditions of this study, no embryotoxic or teratogenic effects were observed in the CD rats following dermal application of formulation P-23 containing 1.5% of sodium lauriminodipropionate, once every three days over the gestation period.
- Executive summary:
In a developmental toxicity study, one hair dye formulation containing 1.5% of sodium lauriminodipropionate was administered topically to groups of 20 CD female rats at a dose level of 2 mL/kg on days 1, 4, 7, 10, 13, 16 and 19 of gestation. Pilot study had shown that the potential skin irritancy would not permit more frequent application. Three negative control groups were tested in this study. The positive control group received acetylsalicylic acid by gavage at a dose of 250 mg/kg on days 6 through 16 of gestation.
Twenty pregnant rats from each group were sacrificed on day 20 of gestation, and Cesarean sections were performed.
No signs of toxicity were seen throughout the study, except for the changes in the color of the skin and hair at the site of dye application. No irritation or other changes in appearance were seen. Changes in female body weights were similar for rats in the untreated controls and the treated group. A marked reduction in maternal weight gain through gestation was observed in the rats receiving acetyl-salicylic acid (positive control) as compared with either the untreated control rats or dye-treated rats. Mean food consumption for all groups (treated + untreated) throughout gestation was similar except for rats in the acetylsalicylic acid group. These rats showed a moderates decrease in food consumption from days 7 to 13 of gestation. This decrease was not observed from days 13 to 20 of gestation.
No significant differences were observed between the treated and untreated groups in the mean number of corpora lutea, implantation sites and live fetuses and the sex ratio. No differences between groups were seen regarding the number of females exhibiting resorption sites or mean resorptions per pregnancy. No significant changes were observed regarding soft-tissue anomalies between the dye-treated group and the untreated control groups. The skeletal variation observed in this study was accessory ribs. However, this variation was more frequent in the untreated animals than the treated group. Increase in embryo-death and decrease in fetal weight were observed in the positive control group.
Under the test conditions of this study, no embryotoxic or teratogenic effects were observed in the CD rats following dermal application of formulation P-23 containing 1.5% of sodium lauriminodipropionate, every every three days over the gestation period.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.